Opioids for chronic non-cancer pain: a protocol for a systematic review of randomized controlled trials.

Keyphrases

• Adverse Events 28%
• Anchor-based 14%
• Assessment Approach 14%
• Assessment Development 28%
• Assessment System 14%
• Chronic Noncancer Pain 100%
• Clinical Trials 28%
• Development Approach 14%
• Developmental Systems 14%
• Evaluation Approach 14%
• Evaluation Assessment 28%
• Evaluation System 14%
• Evidence-based Management 14%
• Functional Benefit 14%
• Gain Guiding 14%
• Grading of Recommendations 28%
• Initiative on Methods 28%
• Measurements Assessment 28%
• Meta-analysis 14%
• Method Assessment 28%
• Minimal Clinically Important Difference 14%
• Non-opioid 14%
• Opioid Therapy 14%
• Opioid Use 14%
• Opioids 100%
• Pain Assessment 28%
• Patient Management 14%
• Patient-important Outcomes 14%
• Prospero 14%
• Randomized Controlled Trial 100%
• Recommendation Approach 14%
• Recommendation System 14%
• Relative Effect 14%
• Risk Difference 14%
• Risk Measures 14%
• Risk of Bias 14%
• Subgroup Analysis 14%
• Systematic Meta-analysis 14%
• Trial Eligibility 14%

Medicine and Dentistry

• Adverse Event 28%
• Attributable Risk 14%
• Cancer Pain 100%
• Clinical Trial 28%
• Meta-Analysis 14%
• Minimal Clinically Important Difference 14%
• Opiate 100%
• Pain Assessment 28%
• Randomized Controlled Trial 100%
• Subgroup Analysis 14%
• Systematic Review 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 28%
• Cancer Pain 100%
• Clinical Trial 28%
• Opiate 100%
• Randomized Controlled Trial 100%